The best Chinese pharmaceutical maker Hengrui rises in Hong Kong Commercial for the first time

For the first time in Hengrui, which comes in the wake of the first show of the Catl program in Hong Kong, it depends on the Hong Kong Lists Market – where revenue is expected to double to more than $ 22 billion this year.

May James – Sopa/Lightrocto Pictures via Getty Images